Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma

Fig. 5

Validation of 20-gene signature in patients with relapsed MM obtained from the GSE9782 dataset (n = 264). a Kaplan–Meier survival curves; b Time-dependent operating characteristic analysis for survival prediction by our 20-gene risk model, International Staging System stage (ISS), and RNAseq-based signature in the GSE9782 set; c the distribution of 20-gene signature risk scores; d patients’ survival status and times; e the heatmap of 20 genes expression in patients from the training set

Back to article page